期刊文献+

改性壳聚糖与碘的络合物抑菌性质研究 被引量:3

Study on Bacteriostasis of Complex Compound by Modified Chitosan with Iodine
下载PDF
导出
摘要 壳聚糖(CTS)与水杨醛反应制得壳聚糖衍生物(RS-CTS),在碱性条件下羧甲基化得羧甲基壳聚糖衍生物(RS-CMC).制备RS-CMC和碘的络合物(RS-CMC-I2),UV光谱、IR谱对RS-CMC进行了表征.分析RS-CMC与碘络合物的抑菌性质,其对细菌敏感度为高度敏感. Chitosan derivative (RS-CTS) was obtained by chitosan with salicylaldehyde. Carboxymethyl chitosan derivative(RS-CMC) was prepared by carboxymethl reaction in alkaline condition. The complex compound of RS-CMC with the iodine was synthesized and characterized by UV spectrum and IR spectrum. The bacteriostasis of the complex compound (RS-CMC-I2) was analysed. The bacteriostasis degree of RS-CTS-I2 is high sensitive grade.
出处 《上海工程技术大学学报》 CAS 2008年第4期295-298,共4页 Journal of Shanghai University of Engineering Science
基金 上海市自然科学基金资助项目(06ZR14038)
关键词 改性壳聚糖 络合物 抑菌 modified chitosan iodine complex compound bacteriostasis
  • 相关文献

参考文献5

  • 1NO H K, PARK N Y, LEE S H, et al. Antibacterial activities of chitosan and chitosan oligomers with different molecular weights on spoilage bacteria isolated from tofu [J ]. Journal of Food Science, 2002, 67 (4): 1511 - 1514.
  • 2JIN J ,SONG M. Chitosan andchitosan-PEO blend membranes crosslinked by genipin for drug rdease[J] .Journal of Applied Polymer Science,2006,102 ( 1 ) : 436 - 444.
  • 3DHIMAN H K,RAY A R,PANDA A K. Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines[J]. Biomaterials,2004,25(21) :5147 - 5154.
  • 4MITYA S,GAUR U,GHOSH P C, et al. Tumour targeted delivery of encapsulated dextran doxorubicin conjugate using chitosan nanoparticles as carrier[J]. J Control Release, 2001,74 (3) : 317 - 323.
  • 5丁德润,薄兰君,梁爱斌.壳聚糖及其衍生物与碘的络合物的抑菌性质研究[J].精细化工,2006,23(9):903-906. 被引量:10

二级参考文献8

  • 1Olsen R,Schwartzmiller D,Weppner W,et al.Biomedical application of chitin and its derivatives[J].Elsevier Applied Science,2003,13(37):813-818.
  • 2Jameela S R,Jayakrishnan A.Glutaraldehyde crosslinked chitosan microspheres and a long acting biodegradable drug delivery vehicle:studes on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle[J].Biomaterial,2003,16(10):769-773.
  • 3Rao S B,Sharma C P.Use of chitosan as a biomaterial:studies on its safety and hemostatic potential[J].Biomed Mater Res,2002,34(1):21-26.
  • 4Peluso G,Petillo O,Ranieri M,et al.Chitosan-mediated stimulation of macrophage function[J].Biomaterial,2004,15(15):1215-1220.
  • 5Hassan E R,Parish R C,Gallo J M.Optimized formulation of magnetic chitosan microspheres containing the anticancer agent,oxantrazole[J].Pharm Res,2002,9(3):390-396.
  • 6No H K,Park N Y,Lee S H.Antibacterial activities of chitosan and chitosan oligomers with different molecular weights on spoilage bacteria isolated from Tofu[J].Journal of Food Science,2002,67(4):1551-1514.
  • 7Lim S H,Hudson S M.Synthesis and antimicrobial activity of a water-soluble chitosan derivative with a fiber-reactive group[J].Carbohydrate Research,2004,339:313-319.
  • 8丁德润,陈燕青,刘鸿志.降解壳聚糖与水杨醛改性衍生物对Ca^(2+)、Fe^(3+)的螯合性质[J].精细化工,2003,20(4):247-249. 被引量:14

共引文献9

同被引文献37

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部